Company Filing History:
1 out of 832,912 Years Active: 2009
Title: The Innovations of Patrick Cossette
Introduction
Patrick Cossette is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of epilepsy research, particularly in understanding idiopathic generalized epilepsy (IGE). His work focuses on identifying genetic factors that contribute to this neurological disorder.
Latest Patents
Patrick Cossette holds a patent titled "SCN3A locus for idiopathic generalized epilepsy, mutations thereof and method using same." This invention relates to the identification of three genes mapping to chromosome 2, which show mutations in patients with epilepsy. The patent encompasses nucleic acid sequences and protein sequences of these loci (SCNA) and their applications in assessing, diagnosing, prognosing, or treating epilepsy. It also aims to predict an epileptic individual's response to medication and identify agents that modulate the function of the SCNA. Furthermore, the invention provides screening assays using SCN1A, SCN2A, and/or SCN3A to identify compounds with therapeutic benefits for epilepsy and related neurological disorders.
Career Highlights
Throughout his career, Patrick Cossette has focused on advancing the understanding of epilepsy through innovative research. His work has led to important discoveries that have the potential to improve treatment options for individuals affected by this condition.
Collaborations
Patrick has collaborated with esteemed colleagues in the field, including Guy A Rouleau and Ronald G Lafreniere. These partnerships have enhanced the impact of his research and contributed to the advancement of knowledge in epilepsy.
Conclusion
Patrick Cossette's contributions to epilepsy research through his innovative patent highlight the importance of genetic understanding in treating neurological disorders. His work continues to pave the way for future advancements in the field.